Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Alida L.P. Caforio(University of Padua), Sabine Pankuweit(Universitätsklinikum Gießen und Marburg), Eloisa Arbustini, Cristina Basso(University of Padua), Juan R. Gimeno(Hospital Universitario Virgen de la Arrixaca), Stephan B. Felix(Universität Greifswald), Michael Fu(University of Gothenburg), Tiina Heliö(Helsinki University Hospital), Stéphane Heymans(Maastricht University Medical Centre), Roland Jahns, Karin Klingel(University Children's Hospital Tübingen), Aleš Linhart(Charles University), Bernhard Maisch(Universitätsklinikum Gießen und Marburg), William J. McKenna(UCL Australia), Jens Mogensen(Odense University Hospital), Yigal M. Pinto(Academic Medical Center), Arsen Ristić(University of Belgrade), Heinz‐Peter Schultheiß(Charité - Universitätsmedizin Berlin), Hubert Seggewiß(Leopoldina Krankenhaus Schweinfurt), Luigi Tavazzi(Maria Cecilia Hospital), Gaetano Thiene(University of Padua), Atilla Yılmaz(Robert Bosch Hospital), Philippe Charron(Laboratoire National de Référence), Perry Elliott(UCL Australia)
Cited by 3,392Open Access
Abstract
In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases an expert consensus group reviews the current knowledge on clinical presentation, diagnosis and treatment of myocarditis, and proposes new diagnostic criteria for clinically suspected myocarditis and its distinct biopsy-proven pathogenetic forms. The aims are to bridge the gap between clinical and tissue-based diagnosis, to improve management and provide a common reference point for future registries and multicentre randomised controlled trials of aetiology-driven treatment in inflammatory heart muscle disease.
Related Papers
No related papers found
Powered by citation graph analysis